ABSIAbsci CorporationBATS:ABSIStockHunter88Absci reported positive interim results from its HEADLINE Phase 1 trial of ABS-201, its AI-designed antibody targeting the prolactin receptor. Absci previously said it anticipated signing one or more partnerships during 2026, including potentially with a Large Pharma company. I now have a potential swing trade setup signal for ABSI. I'm looking to enter long if the stock can manage to stay above my "Entry Level". If triggered, I will then place a stop-loss at the "SL" line. If it eventually reaches my Take Profit target (TP) I will then sell half my position and utilize the 8-EMA as my trailing stop. The setup will remain valid for five trading days or until it closes below the "SL", whichever comes first.